References

  1. Eugène Devic. Myélite subaiguë compliquée de névrite optique. Bull Med. 1894;8:1033-4. PubMed | Google Scholar

  2. Fernand Gault. De la neuromyélite optique aiguë, Thèse de médecine. Faculté de Médecine et de Pharmacie de Lyon. 1894. Google Scholar

  3. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999 Sep 22;53(5):1107-14. PubMed | Google Scholar

  4. Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol. 2002 Jun;22(2):105–22. PubMed | Google Scholar

  5. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain. 2002 Jul;125(Pt 7):1450-1461. PubMed | Google Scholar

  6. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17;364(9451):2106-12. PubMed | Google Scholar

  7. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep;6(9):805-815. PubMed | Google Scholar

  8. Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet. 2003 Mar 15;361(9361): 889-90. PubMed | Google Scholar

  9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23;66(10):1485-. PubMed | Google Scholar

  10. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapsein multiple sclerosis: Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998 Jul 30;339(5):285-91. PubMed | Google Scholar

  11. Kim W, Kim SH, Nakashima I, Takai Y, Fujihara K, Leite MI, Kitley J, Palace J, Santos E, Coutinho E, Silva AM, Kim BJ, Kim BJ, Ahn SW, Kim HJ. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology. 2012 Apr 17;78(16):1264-7. PubMed | Google Scholar

  12. Bourre B, Marignier R, Zéphir H, Papeix C, Brassat D, Castelnovo G, Collongues N, Vukusic S, Labauge P, Outteryck O, Fontaine B, Vermersch P, Confavreux C, de Seze J; NOMADMUS Study Group. Neuromyelitis optica and pregnancy. Neurology. 2012 Mar 20;78(12):875-9. PubMed | Google Scholar

  13. Fragoso YD, Adoni T, Bichuetti DB, Brooks JBB, Ferreira MLB, Oliveira EM, Oliveira CL, Ribeiro SB, Silva AE, Siquineli F. Neuromyelitis optica and pregnancy. J Neurol. 2013 Oct;260(10):2614-9. PubMed | Google Scholar

  14. Bencherifa F, Bourassi A, Mellal Z, Berraho A. Devic's neuro-optic myelitis and pregnancy. J Fr Ophtalmol. 2007 Sep;30(7):737-743. PubMed | Google Scholar

  15. Bonnet F, Mercié P, Morlat P, Hocke C, Vergnes C, Ellie E, Viallard JF, Faure I, Pellegrin JL, Beylot J, Leng B. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus. 1999;8(3):244-247. PubMed | Google Scholar

  16. Shang W, Liu J. Neuromyelitis optica during pregnancy. Int J Gynaecol Obstet. 2011 Oct;115(1):66–68. PubMed | Google Scholar

  17. Tsugawa J, Tsuboi Y, Inoue H, Baba Y, Yamada T. A case of anti-aquaporin 4 antibody-positive Sjögren syndrome associated with a relapsed myelitis in pregnancy. Insho Shinkeigaku. 2010 Jan;50(1):27–30. Article en japonais. PubMed | Google Scholar

  18. Asgari N, Henriksen TB, Petersen T, Lillevang ST, Weinshenker BG. Pregnancy outcomes in a woman with neuromyelitis optica. Neurology. 2014 Oct 21;83(17):1576-1577. PubMed | Google Scholar

  19. Sadana N, Houtchens M, Farber MK. Anesthetic management of a parturient with neuromyelitis optica. Int J Obstet Anesth. 2012 Oct;21(4):371-375. PubMed | Google Scholar

  20. Pellkofer HL, Suessmair C, Schulze A, Hohlfeld R, Kuempfel T. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Mult Scler. 2009 Aug;15(8):1006-1008. PubMed | Google Scholar

  21. Ringelstein M, Harmel J, Distelmaier F, Ingwersen J, Menge T, Hellwig K, Kieseier B, Mayatepek E, Hartung HP, Kuempfel T, Aktas O. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Mult Scler. 2013 Oct;19(11):1544–1547. PubMed | Google Scholar

  22. Jurewicz A, Selmaj K. Relapse of neuromyelitis optica during pregnancy : treatment options and literature review. Clin Neurol Neurosurg. 2015 Mar;130(1):159-161. PubMed | Google Scholar

  23. Cornelio DB, Braga RP, Rosa MW, Ayub AC. Devic’s neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Arch Gynecol Obstet. 2009 Sep;280(3):475-7. PubMed | Google Scholar

  24. Gunaydin B, Akcali D, Alkan M. Epidural anaesthesia for caesarean section in a patient with Devic's syndrome. Anaesthesia. 2001 Jun;56(6):565–7. PubMed | Google Scholar

  25. Papeix C, Vidal JS, De Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007 Mar;13(2):256-259. PubMed | Google Scholar

  26. Mao-Draayer Y, Braff S, Pendlebury W, Panitch H. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology. 2002 Oct 8;59(7):1074-1077. PubMed | Google Scholar

  27. Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler. 2009 Apr;15(4):487-492. PubMed | Google Scholar

  28. Gold R, Hartung HP. Towards individualised multiple-sclerosis therapy. Lancet Neurol. 2005Nov;4(11):693-694. PubMed | Google Scholar

  29. Magaña SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul;68(7):870-878. PubMed | Google Scholar

  30. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002 Jan 8;58(1):143-6. PubMed | Google Scholar

  31. Bennetto L, Totham A, Healy P, Massey E, Scolding N. Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system: a report of six cases. J Neurol. 2004 Dec;251(12):1515-21. PubMed | Google Scholar

  32. Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis. Arch Neurol. 2004 Oct;61(10):1515-1520. PubMed | Google Scholar

  33. Soelberg-Sorensen P. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Neurodegenerative Dis. 2008;5(1):8–15. PubMed | Google Scholar

  34. Vukusic S, Marignier R. Multiple sclerosis and pregnancy in the ‘treatment era’. Nat Rev Neurol. 2015 May;11(5):280-9. PubMed | Google Scholar

  35. Kim SH, Jeong IH, Hyun JW, Joung A, Jo HJ, Hwang SH, Yun S, Joo J, Kim HJ. Treatment outcomes with rituximab in 100 patients with neuromyelitis optica. JAMA Neurol. 2015 Sep;72(9):989-995. PubMed | Google Scholar

  36. Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol. 2011 Nov;68(11):1412-20. PubMed | Google Scholar

  37. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Treatment of neuromyelitis optica with rituximab. Arch Neurol. 2008 Nov;65(11):1443-8. PubMed | Google Scholar

  38. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004 Jun 17;350(25):2572-81. PubMed | Google Scholar